InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+30.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Sukhtian Faisal Ghiath, 董事. Director active across 1 company, notably Outlook Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €150k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 29 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sukhtian Faisal Ghiath
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
95,398 股@ US$1.04820.060% mcap58.7% 占其流量Common StockSEC:0001649989-26-000008:0
标准退出：2026年10月27日 (T+90)
30,000 股@ US$1.2947.0% 占其流量Common StockSEC:0001209191-22-053357:0
标准退出：2023年1月5日 (T+90)
27,982,529 股Common StockSEC:0000947871-22-000476:0
18,000 股@ US$1.4036.0% 占其流量Common StockSEC:0001209191-21-067648:0
标准退出：2022年3月2日 (T+90)
4 条申报中的 4 条
About Sukhtian Faisal Ghiath
Faisal Ghiath Sukhtian is a Board Member at Outlook Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His expertise is valuable in guiding the company's initiatives.
